Extending the frontiers of resectability in advanced colorectal cancer

European Journal of Surgical Oncology

Volumn 33, Issue SUPPL. 2, 2007, Pages

  Chun, Y S ^a   Vauthey, J N ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Colorectal cancer; Hepatectomy; Metastases; Neoadjuvant therapies

Indexed keywords

BEVACIZUMAB; CAPECITABINE; CETUXIMAB; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ADVANCED CANCER; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CANCER THERAPY; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; LIVER METASTASIS; LIVER RESECTION; LIVER SURGERY; PRIORITY JOURNAL; REVIEW; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; VEIN EMBOLISM;

ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; HEPATECTOMY; HUMANS; LIVER; LIVER NEOPLASMS; NEOPLASM STAGING; PATIENT CARE TEAM; PATIENT SELECTION; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 36749004461     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2007.09.026     Document Type: Review

References (51)

1. Abdalla E.K., Adam R., Bilchik A.J., Jaeck D., Vauthey J.N., and Mahvi D. Improving resectability of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 13 (2006) 1271-1280
2. Alberts S.R., Horvath W.L., Sternfeld W.C., et al. Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study. J Clin Oncol 23 (2005) 9243-9249
3. Ballantyne G.H., and Quin J. Surgical treatment of liver metastases in patients with colorectal cancer. Cancer 71 (1993) 4252-4266
4. Poston G., Adam R., and Vauthey J.N. Downstaging or downsizing: time for a new staging system in advanced colorectal cancer?. J Clin Oncol 24 (2006) 2702-2706
5. Charnsangavej C., Clary B., Fong Y., Grothey A., Pawlik T.M., and Choti M.A. Selection of patients for resection of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 13 (2006) 1261-1268
6. Adson M.A., van Heerden J.A., Adson M.H., Wagner J.S., and Ilstrup D.M. Resection of hepatic metastases from colorectal cancer. Arch Surg 119 (1984) 647-651
7. Abdalla E.K., Vauthey J.N., Ellis L.M., et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239 (2004) 818-825
8. Ekberg H., Tranberg K.G., Andersson R., et al. Determinants of survival in liver resection for colorectal secondaries. Br J Surg 73 (1986) 727-731
9. Pawlik T.M., Abdalla E.K., Ellis L.M., Vauthey J.N., and Curley S.A. Debunking dogma: surgery for four or more colorectal liver metastases is justified. J Gastrointest Surg 10 (2006) 240-248
10. Bolton J.S., and Fuhrman G.M. Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma. Ann Surg 231 (2000) 743-751
11. Scheele J., Stang R., Altendorf-Hofmann A., and Paul M. Resection of colorectal liver metastases. World J Surg 19 (1995) 59-71
12. Pedersen I.K., Burcharth F., Roikjaer O., and Baden H. Resection of liver metastases from colorectal cancer. Indications and results. Dis Colon Rectum 37 (1994) 1078-1082
13. Minagawa M., Makuuchi M., Torzilli G., et al. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg 231 (2000) 487-499
14. Hamady Z.Z., Malik H.Z., Finch R., et al. Hepatic resection for colorectal metastasis: impact of tumour size. Ann Surg Oncol 13 (2006) 1493-1499
15. Cady B., and McDermott W.V. Major hepatic resection for metachronous metastases from colon cancer. Ann Surg 201 (1985) 204-209
16. Pawlik T.M., Scoggins C.R., Zorzi D., et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 241 (2005) 715-722
17. Rosen C.B., Nagorney D.M., Taswell H.F., et al. Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg 216 (1992) 493-504
18. Headrick J.R., Miller D.L., Nagorney D.M., et al. Surgical treatment of hepatic and pulmonary metastases from colon cancer. Ann Thorac Surg 71 (2001) 975-979
19. Shah S.A., Haddad R., Al-Sukhni W., et al. Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma. J Am Coll Surg 202 (2006) 468-475
20. Elias D., Benizri E., Pocard M., Ducreux M., Boige V., and Lasser P. Treatment of synchronous peritoneal carcinomatosis and liver metastases from colorectal cancer. Eur J Surg Oncol 32 (2006) 632-636
21. Bismuth H., Adam R., Levi F., et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 224 (1996) 509-520
22. Jaeck D. The significance of hepatic pedicle lymph nodes metastases in surgical management of colorectal liver metastases and of other liver malignancies. Ann Surg Oncol 10 (2003) 1007-1011
23. Adam R., Avisar E., Ariche A., et al. Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol 8 (2001) 347-353
24. Adam R., Delvart V., Pascal G., et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 240 (2004) 644-657
25. Giacchetti S., Itzhaki M., Gruia G., et al. Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol 10 (1999) 663-669
26. Tournigand C., Andre T., Achille E., et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 22 (2004) 229-237
27. Tanaka K., Adam R., Shimada H., Azoulay D., Levi F., and Bismuth H. Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver. Br J Surg 90 (2003) 963-969
28. Allen P.J., Kemeny N., Jarnagin W., DeMatteo R., Blumgart L., and Fong Y. Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases. J Gastrointest Surg 7 (2003) 109-115
29. Folprecht G., Grothey A., Alberts S., Raab H.R., and Kohne C.H. Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates. Ann Oncol 16 (2005) 1311-1319
30. Benoist S., Brouquet A., Penna C., et al. Complete response of colorectal liver metastases after chemotherapy: does it mean cure?. J Clin Oncol 24 (2006) 3939-3945
31. Nordlinger B, Sorbye H, Collette L, et al. Final results of the EORTC Intergroup randomized phase III study 40983 [EPOC] evaluating the benefit of peri-operative FOLFOX4 chemotherapy for patients with potentially resectable colorectal cancer liver metastases. ASCO Annual Meeting Proceedings, J Clin Oncol 2007;25(18S):LBA5.
32. Peppercorn P.D., Reznek R.H., Wilson P., Slevin M.L., and Gupta R.K. Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer. Br J Cancer 77 (1998) 2008-2011
33. Rubbia-Brandt L., Audard V., Sartoretti P., et al. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 15 (2004) 460-466
34. Aloia T., Sebagh M., Plasse M., et al. Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol 24 (2006) 4983-4990
35. Nordlinger B., Sorbye H., Debois M., et al. Feasibility and risks of pre-operative chemotherapy with FOLFOX 4 and surgery for resectable colorectal liver metastases: interim results of the EORTC Intergroup randomized phase III study 40983. J Clin Oncol 23 (2005) 3528A
36. Vauthey J.N., Pawlik T.M., Ribero D., et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24 (2006) 2065-2072
37. Poon R.T., and Fan S.T. Assessment of hepatic reserve for indication of hepatic resection: how I do it. J Hepatobiliary Pancreat Surg 12 (2005) 31-37
38. Ijichi M., Makuuchi M., Imamura H., and Takayama T. Portal embolization relieves persistent jaundice after complete biliary drainage. Surgery 130 (2001) 116-118
39. Uesaka K., Nimura Y., and Nagino M. Changes in hepatic lobar function after right portal vein embolization. An appraisal by biliary indocyanine green excretion. Ann Surg 223 (1996) 77-83
40. Abdalla E.K., Barnett C.C., Doherty D., Curley S.A., and Vauthey J.N. Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. Arch Surg 137 (2002) 675-680 [discussion: 680-81]
41. Farges O., Belghiti J., Kianmanesh R., et al. Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg 237 (2003) 208-217
42. Madoff D.C., Abdalla E.K., and Vauthey J.N. Portal vein embolization in preparation for major hepatic resection: evolution of a new standard of care. J Vasc Interv Radiol 16 (2005) 779-790
43. Vauthey J.N., Abdalla E.K., Doherty D.A., et al. Body surface area and body weight predict total liver volume in Western adults. Liver Transpl 8 (2002) 233-240
44. Johnson T.N., Tucker G.T., Tanner M.S., and Rostami-Hodjegan A. Changes in liver volume from birth to adulthood: a meta-analysis. Liver Transpl 11 (2005) 1481-1493
45. Vauthey J.N., Pawlik T.M., Abdalla E.K., et al. Is extended hepatectomy for hepatobiliary malignancy justified?. Ann Surg 239 (2004) 722-730
46. Yanaga K., Honda H., Ikeda Y., Nishizaki A.T., Yamamoto K., and Sugimachi K. Significance of liver size in hepatic surgery. HPB Surg 10 (1997) 195-199
47. Kinoshita H., Sakai K., Hirohashi K., Igawa S., Yamasaki O., and Kubo S. Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg 10 (1986) 803-808
48. Makuuchi M., Thai B.L., Takayasu K., et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 107 (1990) 521-527
49. Ribero D., Abdalla E.K., Madoff D.C., Donadon M., Loyer E.M., and Vauthey J.N. Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg 94 (2007) 1386-1394
50. Jaeck D., Oussoultzoglou E., Rosso E., Greget M., Weber J.C., and Bachellier P. A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg 240 (2004) 1037-1049
51. Chun Y.S., Vauthey J.N., Ribero D., et al. Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survival. J Gastrointest Surg 11 (2007) 1498-1505